Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 22
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Outset Medical Inc
OM
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$4.05
-0.17
-4.03%
Dern. MÀJ: Oct 20, 4:05 PM
$4.13
-0.09
-2.13%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Résultats:
Résultats Q3 2026 dans dans 14 jours à partir de maintenant le mer. nov. 4th, après la fermeture du marché
Outset Medical Financials
Outset Medical (OM) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.633M Est
Outset Medical (NASDAQ:OM) affirms FY2026 sales outlook from $125.000 million-$130.000 million to $125.000 million-$130.000 million vs $126.633 million estimate.
Benzinga Newsdesk
PRO
Outset Medical Q2 Adj. EPS $(0.80) Misses $(0.72) Estimate, Sales $31.635M Beat $29.833M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.72) by 11.11 percent. This is a 4.76 percent increase over losses of $(0.84) per share from
Benzinga Newsdesk
PRO
Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.767M Est
Outset Medical (NASDAQ:OM) affirms FY2026 sales outlook from $125.000 million-$130.000 million to $125.000 million-$130.000 million vs $126.767 million estimate.
Benzinga Newsdesk
PRO
Outset Medical Q1 Adj. EPS $(0.83) Misses $(0.79) Estimate, Sales $27.863M Miss $28.900M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.79) by 5.06 percent. This is a 74.38 percent increase over losses of $(3.24) per share from the
Benzinga Newsdesk
Outset Medical Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Outset Medical Sees FY2026 Sales $125.000M-$130.000M vs $127.650M Est
Outset Medical (NASDAQ:OM) sees FY2026 sales of $125.000 million-$130.000 million vs $127.650 million analyst estimate.
Benzinga Newsdesk
